Larvol Delta - TAYLOR003-Fovinaciclib-Plus-Aromatase-Inhibitors-and-Dual-HER2-Blockade-in-a-ResponseAdapted-Neoadjuvant-Strategy-for-HRPositiveHER2Positive-Early-Breast-Cancer

Futuoning (fovinaciclib) - Fochon Pharmaceuticals

Perjeta (pertuzumab) - Roche

Herceptin (trastuzumab) - Roche

http://clinicaltrials.gov/ct2/show/NCT07616427

Jun 2, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next